Stockreport

FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, April 11, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and [Read more]